AMI Clinical Trials

666 recruitingLast updated: May 13, 2026

There are 666 actively recruiting ami clinical trials across 74 countries. Studies span Not Applicable, Phase 2, Phase 4, Phase 3, Phase 1, Early Phase 1. Top locations include Beijing, Beijing Municipality, China, New York, New York, United States, Boston, Massachusetts, United States. Updated daily from ClinicalTrials.gov.


AMI Trials at a Glance

666 actively recruiting trials for ami are listed on ClinicalTrialsFinder across 6 cities in 74 countries. The largest study group is Not Applicable with 281 trials, with the heaviest enrollment activity in Beijing, New York, and Boston. Lead sponsors running ami studies include Cairo University, Peking University First Hospital, and Fondazione Policlinico Universitario Agostino Gemelli IRCCS.

Treatments under study

About AMI Clinical Trials

Looking for clinical trials for AMI? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new AMI trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about AMI clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 666 trials

Recruiting
Phase 1

Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency

Inherited Bone Marrow Failure SyndromeFamilial Platelet Disorder With Predisposition to Myeloid Malignancies
National Cancer Institute (NCI)75 enrolled1 locationNCT06090669
Recruiting

Long Term Follow-up of Mesothelioma Patients and Their Family Members With Germline Mutations in BAP1 and Other Genes

MesotheliomaFamilies
National Cancer Institute (NCI)1,000 enrolled1 locationNCT03830229
Recruiting

Advanced vs Standard Hemodynamic Monitoring During Propofol Sedation for ERCP: A Prospective Study

Hemodynamic Instability
Hitit University32 enrolled1 locationNCT07538115
Recruiting
Not Applicable

Proactive Hemodynamic Management During Cytoreductive Surgery and HIPEC

Ovarian CancerFluid OverloadHemodynamic Instability
Fondazione Policlinico Universitario Agostino Gemelli IRCCS52 enrolled1 locationNCT07070973
Recruiting

Natural History Study of Patients With Excess Androgen

Congenital Adrenal Hyperplasia (CAH)Familial Male-Limited Precocious Puberty (FMPP)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)3,000 enrolled2 locationsNCT00250159
Recruiting
Not Applicable

PrEP Readiness Interventions for Sustained Motivation (PRISM)

HIVMethamphetamine Disorders
Florida International University400 enrolled1 locationNCT06637436
Recruiting
Phase 2

Prevention of Reperfusion Injury Outcomes Through Effective Cardioprotection Targeting Myocardial Infarction

Myocardial InfarctionSTEMI (ST Elevation MI)Reperfusion Injury+1 more
Nyrada Pty Ltd300 enrolled6 locationsNCT07362446
Recruiting

The Impact of Multiple Antihypertensive Therapy on Post-Induction Hypotension Burden in Cardiac Surgery Patients

Antihypertensive AgentsCardiac SurgeryHemodynamics+2 more
Konya City Hospital160 enrolled1 locationNCT07541222
Recruiting

National Network for Cardiovascular Genomics: Advancing Cardiovascular Healthcare for Hereditary Diseases in Brazil's Unified Health System Through a Multicenter Registry

Sudden Cardiac DeathArrhythmogenic Right Ventricular DysplasiaCardiomyopathy, Dilated+11 more
Hospital do Coracao1,211 enrolled27 locationsNCT06546137
Recruiting
Phase 2

Effect of Montelukast on Inflammatory Markers and Cardiac Injury in Patients With Acute Myocardial Infarction

Acute Myocardial Infarction (AMI)
October 6 University80 enrolled1 locationNCT07537868
Recruiting
Phase 3

A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE)

Homozygous Familial Hypercholesterolemia
Arrowhead Pharmaceuticals60 enrolled35 locationsNCT07037771
Recruiting
Not Applicable

The Efficacy and Safety of Short Term S-ketamine Infusion as an Adjunctive Therapy in Patients With Fibromyalgia

EsketamineFibromyalgiaPregabalin
Beijing Tiantan Hospital92 enrolled1 locationNCT07230171
Recruiting
Phase 1Phase 2

Effects of Dexmedetomidine Versus Ketamine on Inflammatory Response and Hemodynamic in Patients

Haemodynamic Rebound
New Valley University2 enrolled1 locationNCT06490731
Recruiting

A Natural History Study of Bone and Mineral Disorders

Tumor Induced OsteomalciaOsteomalaciaFamilial Tumoral Calcinosis
National Institute of Dental and Craniofacial Research (NIDCR)1,000 enrolled1 locationNCT00024804
Recruiting
Phase 2

2-Hydroxybenzylamine (2-HOBA) to Reduce HDL Modification and Improve HDL Function in Familial Hypercholesterolemia (FH)

Familial Hypercholesterolemia
Vanderbilt University Medical Center72 enrolled1 locationNCT04941599
Recruiting

Assessing the Impact of Intensification of Lipid Lowering Therapy With Guidelines-based Evinacumab Administration on Coronary Plaque Volumes Measured by Coronary Computed Tomography Angiography (CCTA) in Patients With Homozygous Familial Hypercholesterolemia (HoFH)

Homozygous Familial Hypercholesterolemia (HoFH)Coronary Computed Tomography Angiography
Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)52 enrolled13 locationsNCT07447648
Recruiting
Not Applicable

AI-SUPPORTED FLIPPED LEARNING IN BREAST SELF-EXAMINATION TRAINING

Breast Self-examinationNursing EducationArtifical Intelligence
Baskent University80 enrolled1 locationNCT07562321
Recruiting

Correlation Between Capillary Refill Time and Perfusion Index in Critically Ill Patients

microcirculationMonitoringHemodynamics Instability+1 more
Hospices Civils de Lyon250 enrolled2 locationsNCT07555041
Recruiting

Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome

Familial CancerMesotheliomaBRCA1-Associated Protein-1 (BAP1) Mutations+1 more
National Cancer Institute (NCI)800 enrolled1 locationNCT04431024
Recruiting
Phase 2Phase 3

A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)

Heterozygous Familial Hypercholesterolemia (HeFH)
Merck Sharp & Dohme LLC153 enrolled25 locationsNCT07058077